The Journal of Organic Chemistry
Article
Scheme 3. Proposed Mechanism
Methyl 6-nitrobenzo[c]isoxazole-3-carboxylate (2f). The
crude product was purified by column chromatography on a silica
gel (n-hexane/ethyl acetate = 8/1). Yellow solid (200 mg, 90%); mp
153−154 °C; 1H NMR (400 MHz, CDCl3): δ = 8.73 (dd, J = 1.8, 0.9
Hz, 1H), 8.14 (dd, J = 9.5, 0.9 Hz, 1H), 8.01 (dd, J = 9.5, 1.8 Hz,
1H), 4.13 (s, 3H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ =
156.9, 156.4, 155.7, 150. 2, 123.2, 121.6, 121.0, 114.4, 53.5 ppm; IR
(neat): vmax 1720, 1268, 1213 cm−1; ESI-HRMS: m/z [M + H]+ calcd
for C9H7N2O5: 223.0349, found: 223.0357.
(neat): vmax 2976, 2842, 1267, 1030 cm−1; ESI-HRMS: m/z [M + H]+
calcd for C13H979BrNO: 273.9862, found: 273.9860.
3-(2-Chlorophenyl)benzo[c]isoxazole (2k). The crude product
was purified by column chromatography on a silica gel (n-hexane/
ethyl acetate = 25/1). Yellow solid (117 mg, 51%); mp 67−68 °C; 1H
NMR (400 MHz, CD3OD): δ = 9.29−9.27 (m, 1H), 9.24−9.22 (m,
1H), 9.19−9.16 (m, 2H), 9.14−9.07 (m, 2H), 8.98 (ddd, J = 9.0, 6.4,
1.0 Hz, 1H), 8.68 (ddd, J = 9.1, 6.4, 0.8 Hz, 1H) ppm; 13C{1H} NMR
(100 MHz, CD3OD): δ = 164.6, 158.5, 134.0, 133.2, 132.8, 132.6,
132.0, 128.7, 128.2, 126.0, 121.9, 117.6, 115.7 ppm; IR (neat): vmax
2956, 2852, 1251, 1021 cm−1; ESI-HRMS: m/z [M + H]+ calcd for
C13H935ClNO: 230.0367, found: 230.0364.
3-(3-Chlorophenyl)benzo[c]isoxazole (2l). The crude product
was purified by column chromatography on a silica gel (n-hexane/
ethyl acetate = 50/1). White solid (112 mg, 49%); mp 85−86 °C; 1H
NMR (400 MHz, CDCl3): δ = 7.98 (s, 1H), 7.90−7.88 (m, 1H), 7.79
(d, J = 8.9 Hz, 1H), 7.62 (d, J = 9.1 Hz, 1H), 7.50−7.43 (m, 2H),
7.33 (ddd, J = 9.1, 6.4, 0.9 Hz, 1H), 7.09 (ddd, J = 8.9, 6.4, 0.7 Hz,
1H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 162.8, 158.0,
135.4, 130.9, 130.7, 130.3, 130.0, 126.5, 125.4, 124.7, 120.3, 115.8,
114.8 ppm; IR (neat): vmax 2966, 2862, 1256, 1021 cm−1; ESI-HRMS:
m/z [M + H]+ calcd for C13H935ClNO: 230.0367, found: 230.0364.
3-(4-Chlorophenyl)benzo[c]isoxazole (2m). The crude prod-
uct was purified by column chromatography on a silica gel (n-hexane/
ethyl acetate = 10/1). White solid (96 mg, 42%); mp 143−144 °C;
1H NMR (400 MHz, CDCl3): δ = 7.97−7.93 (m, 2H), 7.78 (d, J =
8.9 Hz, 1H), 7.62 (d, J = 9.1 Hz, 1H), 7.55−7.51 (m, 2H), 7.33 (ddd,
J = 9.1, 6.4, 0.9 Hz, 1H), 7.08 (ddd, J = 8.9, 6.4, 0.7 Hz, 1H) ppm;
13C{1H} NMR (100 MHz, CDCl3): δ = 163.3, 158.0, 136.5, 130.9,
129.7, 127.8, 126.9, 125.1, 120.4, 115.8, 114.6 ppm; IR (neat): vmax
2926, 2852, 1250, 1022 cm−1; ESI-HRMS: m/z [M + H]+ calcd for
C13H935ClNO: 230.0367, found: 230.0364.
Methyl 6-methylbenzo[c]isoxazole-3-carboxylate (2g). The
crude product was purified by column chromatography on a silica gel
(n-hexane/ethyl acetate = 10/1). Yellow solid (170 mg, 89%); mp
1
67−68 °C; H NMR (400 MHz, CDCl3): δ = 7.80 (d, J = 9.0 Hz,
1H), 7.42 (s, 1H), 7.07 (d, J = 9.0 Hz, 1H), 4.07 (s, 3H), 2.43 (s, 3H)
ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 158.3, 157.7, 153.0,
141.9, 131.6, 119.9, 119.5, 113.6, 52.9, 22.6 ppm; IR (neat): vmax
1708, 1295, 1229 cm−1; ESI-HRMS: m/z [M + H]+ calcd for
C10H10NO3: 192.0655, found: 192.0654.
3-Phenylbenzo[c]isoxazole (2h). The crude product was
purified by column chromatography on a silica gel (n-hexane/ethyl
1
acetate = 2/1). Yellow liquid (68 mg, 35%); H NMR (400 MHz,
CDCl3): δ = 8.03−8.00 (m, 2H), 7.83 (d, J = 8.9 Hz, 1H), 7.61 (d, J
= 9.1 Hz, 1H), 7.57−7.53 (m, 2H), 7.51−7.46 (m, 1H), 7.32 (ddd, J
= 9.1, 6.4, 0.8 Hz, 1H), 7.05 (ddd, J = 8.9, 6.4, 0.6 Hz, 1H) ppm;
13C{1H} NMR (100 MHz, CDCl3): δ = 164.5, 157.9, 130.8, 130.4,
129.4, 128.5, 126.7, 124.7, 120.7, 115.6, 114.5 ppm; IR (neat): vmax
2924, 2852, 1632 cm−1; ESI-HRMS: m/z [M + H]+ calcd for
C13H10NO: 196.0757, found: 196.0754.
3-(2-Methoxyphenyl)benzo[c]isoxazole (2i). The crude prod-
uct was purified by column chromatography on a silica gel (n-hexane/
1
ethyl acetate = 10/1). Yellow liquid (77 mg, 34%); H NMR (400
MHz, CDCl3): δ = 7.83 (dd, J = 7.7, 1.7 Hz, 1H), 7.74 (d, J = 8.9 Hz,
1H), 7.59 (d, J = 9.1 Hz, 1H), 7.49 (ddd, J = 9.1, 7.4, 1.7 Hz, 1H),
7.30 (ddd, J = 9.1, 6.4, 1.0 Hz, 1H), 7.13 (td, J = 7.7, 1.0 Hz, 1H),
7.08 (d, J = 8.4 Hz, 1H), 6.98 (ddd, J = 8.9, 6.4, 0.8 Hz, 1H), 3.94 (s,
3H) ppm; 13C{1H} NMR (100 MHz, CDCl3): δ = 163.5, 157.9,
156.5, 132.0, 130.6, 130.6, 123.4, 122.7, 121.2, 117.8, 116.1, 115.2,
111.8, 55.7 ppm; IR (neat): vmax 2924, 2854, 1251, 1021 cm−1; ESI-
HRMS: m/z [M + H]+ calcd for C14H12NO2: 226.0863, found:
226.0860.
3-(3-(Trifluoromethyl)phenyl)benzo[c]isoxazole (2n). The
crude product was purified by column chromatography on a silica
gel (n-hexane/ethyl acetate = 10/1). Yellow solid (153 mg, 58%); mp
1
114−115 °C; H NMR (400 MHz, CDCl3): δ = 7.27 (s, 1H), 8.21
(d, J = 7.6 Hz, 1H), 7.82 (d, J = 8.9 Hz, 1H), 7.76−7.68 (m, 2H),
7.65 (d, J = 9.1 Hz, 1H), 7.36 (ddd, J = 9.1, 6.4, 0.9 Hz, 1H), 7.13
(ddd, J = 8.9, 6.4, 0.7 Hz, 1H) ppm; 13C{1H} NMR (100 MHz,
CDCl3): δ = 162.7, 158.1, 132.0 (JF‑C = 32.7 Hz), 131.0, 130.0, 129.7
3-(2-Bromophenyl)benzo[c]isoxazole (2j). The crude product
was purified by column chromatography on a silica gel (n-hexane/
(JF‑C = 1.2 Hz), 129.2, 126.8 (JF‑C = 3.7 Hz), 125.7, 123.8 (JF‑C
270.9 Hz), 123.4 (JF‑C = 3.9 Hz), 120.1, 116.0, 115.0 ppm; IR (neat):
max 2960, 2923, 2848, 1318, 1107 cm−1; ESI-HRMS: m/z [M + H]+
=
1
ethyl acetate = 10/1). Yellow liquid (120 mg, 44%); H NMR (400
v
MHz, CD3OD): δ = 9.40 (dd, J = 8.0, 1.0 Hz, 1H), 9.20 (dd, J = 7.7,
1.8 Hz, 1H), 9.17−9.11 (m, 3H), 9.07−9.02 (m, 1H), 8.97 (ddd, J =
9.1, 6.4, 1.0 Hz, 1H), 8.66 (ddd, J = 8.9, 6.4, 0.7 Hz, 1H) ppm;
13C{1H} NMR (100 MHz, CD3OD): δ = 165.9, 158.4, 135.2, 133.4,
133.1, 132.6, 130.3, 129.1, 126.0, 123.2, 121.8, 117.4, 115.7 ppm; IR
calcd for C14H9F3NO: 264.0631, found: 264.0627.
Methyl 4-(benzo[c]isoxazol-3-yl)benzoate (2o). The crude
product was purified by column chromatography on a silica gel (n-
hexane/ethyl acetate = 6/1). Yellow solid (139 mg, 55%); mp 152−
153 °C; 1H NMR (400 MHz, CDCl3): δ = 8.23−8.20 (m, 2H), 8.11−
7329
J. Org. Chem. 2021, 86, 7326−7332